Radyasyona Maruz Kalan Hastaların Acil Olarak İlk Yaklaşım
Özet
Radyasyon, insanlarda haklı bir korku uyandıran, maruziyet derecesinin ve biyolojik hasarlarının belirlenmesi için özel ekipmanlar ile klinik değerlendirmelere ihtiyaç duyan travmatik bir ajandır. Bu durum karşısında geliştirilen acil müdahale stratejileri; hızı, güvenliği ve etkinliği optimize etmeyi amaçlamaktadır. İlk aşamada, hastane ortamını korumak ve sağlık çalışanlarının güvenliğini sağlamak amacıyla acil servis dışında iki basamaklı (birincil ve genişletilmiş) bir triaj alanı ile dekontaminasyon bölgesi kurulmalıdır. Hayati tehdit oluşturan travma veya yanık bulguları olan hastaların öncelikle stabilize edilmesi kritik önem taşır; çünkü stabilizasyon, radyasyon yönetiminden her zaman önceliklidir. Klinik yönetimde radyasyon dozu; lenfosit sayısındaki değişimler, prodromal semptomlar ve altın standart olan disentrik kromozom testi ile tahmin edilerek düşük, orta, yüksek ve lethal olarak sınıflandırılır. Tedavi protokolleri bu evrelemeye göre (Grade 1-4) şekillenir; destekleyici tedaviler, sıvı-elektrolit replasmanları, antimikrobiyal profilaksi, kutanöz ve gastrointestinal bariyer koruyucuları ile hematopoetik sistemi destekleyen sitokin uygulamalarını içerir. İç kontaminasyon durumlarında ise potasyum iyodür veya Prusya mavisi gibi spesifik şelatlama ajanlarına hızla erişilmelidir. Son olarak, hastaların akut semptomları ortalama iki ayda iyileşirken, uzun vadeli psikolojik ve onkolojik riskler açısından kişiselleştirilmiş takip programları uygulanmalıdır.
Radiation is a traumatic agent that induces fear in humans, requiring specialized equipment and comprehensive clinical evaluations to determine exposure severity and subsequent biological damage. Emergency response strategies developed for these scenarios aim to optimize speed, safety, and therapeutic efficacy. Initially, to protect the hospital infrastructure and ensure healthcare worker safety, a two-stage triage (primary and extended) and a dedicated decontamination zone must be established outside the emergency department. Actively stabilizing patients with life-threatening traumatic injuries or severe burns is paramount, as medical stabilization strictly takes precedence over radiation management. In clinical management, the radiation dose is estimated via lymphocyte counts, prodromal symptoms, and the gold-standard dicentric chromosome assay, classifying exposure into mild, moderate, severe, and lethal levels. Treatment protocols are tailored according to this grading system (Grades 1-4), encompassing comprehensive supportive care, fluid-electrolyte replacements, empirical antimicrobial prophylaxis, cutaneous and gastrointestinal barrier protections, and cytokine therapies to support hematopoietic recovery. In cases involving internal contamination, prompt access to specific decorporation and blocking agents, such as potassium iodide or Prussian blue, is critical. Finally, while acute lesions typically heal within a two-month window, patients mandate personalized, long-term follow-up programs to monitor psychological distress and potential delayed oncological complications.
Referanslar
Reeves GI. Radiation Injuries. Crit Care Clin. 1999; 15: 457-473.
Copplestone D, Hirth G, Johansen M, Lazo E, Takala J, Sakai K, et al. Implementation of the integrated approach in different types of exposure scenarios. Ann ICRP. 2018; 47: 304-312.
Tonnessen BH, Pounds L. Radiation physics. J Vasc Surg. 2011; 53: 65-85.
Allen YJ, Dainiak N, Wingard JR. Clinical manifestations, evaluation, and diagnosis of acute radiation exposure. UpToDate. Erişim tarihi: 19 Ekim 2021.
Mole RH. The LD50 for uniform low LET irradiation of man. Br J Radiol. 1984; 57(677): 355.
Rutherford MW, Seward JP. Radiation injuries and illnesses in pediatric emergency medicine. Clin Pediatr Emerg Med. 2001; 2:141.
Dainiak N. Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res. 2018; 59(suppl_2): ii54.
orise.orau.gov/reacts/index.htlm Erişim tarihi: 28 Ekim 2021.
Sugarman SL, Findley WM, Toohey RE, Dainiak N. Rapid Response, Dose Assessment, and Clinical Management of a Plutonium-contaminated Puncture Wound. Health Phys. 2018; 115: 57.
Wolbarst AB, Wiley AL Jr, Nemhauser JB, Christensen DM, Hendee WR. Medical response to majör radiologic: emergency a primer for medical and public health practitioners. Radiology. 2010, 254: 660.
Bushberg JT, Kroger LA, Hartman MB, Leidholdt EM Jr, Miller KL, Derlet R, Wraa C. Nuclear/radiological terrorism: emergency department management of radiation casualties. J Emerg Med. 2007; 32: 71.
Finch SC. Landmark perspective: Acute radiation syndrome. JAMA 1987; 258: 664.
Dainiak N, Gent RN, Carr Z, Schneider R, Bader J, Buglova E, et al. Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep. 2011; 5: 183.
Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, et al. Medical Management of the acute radiation syndrome: Recomendations of the strategic national stockpile radiation working group. Ann Intern Med 2004; 140: 1037.
Barnett GC, West CM, Dunning AM, Elliott RM, Coles CE, Pharoah PD, Burnet NG. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 2009; 9(2): 134.
Miller RW. Special susceptibility of the child to certain radiation-induced cancers. Environ Health Perspect. 1995; 103: 41–44.
Somasundaram DJ, van de Put WACM. Management of trauma in special populations after a disaster. J Clin Psychiatry. 2006; 67: 64–73.
Coleman CN, Sullivan JM, Bader JL, Murrain-Hill P, Koerner JF, Garrett AL, et al. Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise. Health Phys. 2015; 108: 149.
Dainiak N, Delli Carpini D, Bohan M, Werdmann M, Wilds E, Barlow A, et al. Development of a statewide hospital plan for radiologic emergencies. Int J Radiat Oncol Biol Phys. 2006; 65:16.
Mettler FA Jr, Voelz GL. Major radiation exposure-what to expect and how to respond. N Eng J Med. 2002; 346: 1554.
Guidance for Radiation Accident Management. www.orau.gov/reacts/guidance.htm Erişim tarihi: 23 Kasım 2021.
https://oparu.uni-ulm.de/xmlui/bitstream/handle/123456789/1650/vts_6891_9573. pdf?sequence=1&isAllowed=y Erişim tarihi: 30 Ekim 2021.
Dainiak N, Gent RN, Carr Z, Schneider R, Bader J, Buglova E, et al. First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disaster Med Public Health Prep. 2011; 5: 202.
Gorin NC, Fliedner TM, Gourmelon P, Ganser A, Meineke V, Sirohi B, et al. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol. 2006; 85(10): 671.
Wong K, Chang PY, Fielden M, Downey AM, Bunin D, Bakke J, et al. Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates. Int J Radiat Biol. 2020; 96: 155.
https://remm.hhs.gov/int_contamination.htm#blockingagents
https://www.cdc.gov/nceh/radiation/emergencies/index.htm
Linet MS, Kazzi Z, Paulson JA, Councıl On Envıronmental Health. Pediatric Considerations Before, During, and After Radiological or Nuclear Emergencies. Pediatrics. 2018;142(6).
Zanzonico PB, Becker DV. Effects of time of administration and dietary iodine levels on potassium iodide (KI) blockade of thyroid irradiation by 131I from radioactive fallout. Health Phys. 2000; 78(6): 660.
Hartmann EE, Stout AU, Lynn MJ, Yen KG, Kruger SJ, Lambert SR, et al. Stereopsis results at 4.5 years of age in the infant aphakia treatment study. Am J Ophthalmol. 2015; 159: 64-70.
